Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Jelliffe

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2009
Voriconazole pharmacokinetics and pharmacodynamics in childrenMichael Neely, Teresa Rushing, Andrea Kovacs, et al.
The AAPS Journal|November 15, 2022
Individualized Patient Care Through Model-Informed Precision Dosing: Reflections on Training Future PractitionersRoger Jelliffe, Jiang Liu, George L Drusano, et al.
Biomed Research International|March 14, 2013
Amikacin population pharmacokinetics in critically ill Kuwaiti patientsKamal M Matar, Yousef Al-lanqawi, Kefaya Abdul-Malek, et al.
Clinical Pharmacokinetics|April 6, 2006
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studiesAida Bustad, Dimiter Terziivanov, Robert Leary, et al.
Clinical Pharmacokinetics|May 13, 2003
Aminoglycoside dosages and nephrotoxicity: quantitative relationshipsFlorent Rougier, Michel Ducher, Michel Maurin, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
Aminoglycoside nephrotoxicity: modeling, simulation, and controlFlorent Rougier, Daniel Claude, Michel Maurin, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 15, 2013
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantationAnders Åsberg, Karsten Midtvedt, Mike van Guilder, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 14, 2013
Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric BayesianTatiana Tatarinova, Michael Neely, Jay Bartroff, et al.
Pharmacological Research|June 25, 2011
Nonparametric population modeling and Bayesian analysisRoger Jelliffe, Michael Neely, Alan Schumitzky, et al.
Antimicrobial Agents and Chemotherapy|September 9, 2010
Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteersMichael Neely, Laurent Decosterd, Aurélie Fayet, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2009
Voriconazole pharmacokinetics and pharmacodynamics in childrenMichael Neely, Teresa Rushing, Andrea Kovacs, et al.
The AAPS Journal|November 15, 2022
Individualized Patient Care Through Model-Informed Precision Dosing: Reflections on Training Future PractitionersRoger Jelliffe, Jiang Liu, George L Drusano, et al.
Biomed Research International|March 14, 2013
Amikacin population pharmacokinetics in critically ill Kuwaiti patientsKamal M Matar, Yousef Al-lanqawi, Kefaya Abdul-Malek, et al.
Clinical Pharmacokinetics|April 6, 2006
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studiesAida Bustad, Dimiter Terziivanov, Robert Leary, et al.
Clinical Pharmacokinetics|May 13, 2003
Aminoglycoside dosages and nephrotoxicity: quantitative relationshipsFlorent Rougier, Michel Ducher, Michel Maurin, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
Aminoglycoside nephrotoxicity: modeling, simulation, and controlFlorent Rougier, Daniel Claude, Michel Maurin, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 15, 2013
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantationAnders Åsberg, Karsten Midtvedt, Mike van Guilder, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 14, 2013
Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric BayesianTatiana Tatarinova, Michael Neely, Jay Bartroff, et al.
Pharmacological Research|June 25, 2011
Nonparametric population modeling and Bayesian analysisRoger Jelliffe, Michael Neely, Alan Schumitzky, et al.
Antimicrobial Agents and Chemotherapy|September 9, 2010
Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteersMichael Neely, Laurent Decosterd, Aurélie Fayet, et al.
Pageof 3